trending Market Intelligence /marketintelligence/en/news-insights/trending/nWE930XN4xQvs-Ayijc7iw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

One Rock Capital to acquire Innophos for $932M

StreetTalk – Episode 70: Banks' Liquidity Conundrum Could Fuel M&A Activity

Street Talk Episode 70 - Banks' Liquidity Conundrum Could Fuel M&A Activity

StreetTalk – Episode 69: Banks left with pockets full of cash and few places to go

Street Talk – Episode 69: Banks left with pockets full of cash and few places to go

One Rock Capital to acquire Innophos for $932M

One Rock Capital Partners LLC agreed to acquire specialty chemicals producer Innophos Holdings Inc. for approximately $932 million, including debt.

The middle-market private equity firm will acquire all the outstanding shares of Innophos at $32.00 apiece in cash, which represents an 18% premium to the 30-trading day volume-weighted average closing share price of Innophos' common stock ended Sept. 9.

Innophos produces essential ingredients used by food, health, nutrition and industrial markets.

The transaction, approved unanimously by the board of Innophos, is expected to close in the first quarter of 2020, subject to stockholder and regulatory approvals and other customary closing conditions. Innophos will become a privately held company upon the deal's completion.

As part of the agreement, Innophos has a 30-day "go-shop" period to solicit alternative acquisition proposals.

One Rock intends to fund the transaction through a combination of committed equity financing by its affiliates in addition to committed debt financing from several financial institutions.

Lazard and Baker Botts LLP are serving as the respective exclusive financial adviser and legal counsel to Innophos. Latham & Watkins LLP is the legal counsel to One Rock, and RBC Capital Markets LLC is its financial adviser.